Skip to main content
Divya Yerramilli, MD, Radiation Oncology, New York, NY

Divya Yerramilli MD MBE


Co-Director, Inpatient Radiation Oncology Consult Service

Request Appointment
  • 1275 York AvenueNew York, NY 10065

  • Book by Phone+1(270) 515-5498

Overview of  Dr. Yerramilli

Dr. Divya Yerramilli is a Radiation Oncologist based in New York, NY, currently serving as an Assistant Attending at Memorial Sloan Kettering Cancer Center. She completed her medical education at the Perelman School of Medicine at the University of Pennsylvania, followed by residencies at Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School. Her expertise includes bone pain palliation, oncologic emergencies, and brain metastases. Dr. Yerramilli has contributed to several publications and clinical trials, focusing on topics such as palliative radiation therapy and the management of oncologic emergencies. She also has expertise in medical ethics.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2015 - 2019
  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2014 - 2018
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2014
  • Duke University
    Duke UniversityBS, Biology, Cum Laude, 2006 - 2010

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2023 - Present
  • NJ State Medical License
    NJ State Medical License 2019 - 2027
  • NY State Medical License
    NY State Medical License 2019 - 2026
  • MA State Medical License
    MA State Medical License 2019 - 2021
  • PA State Medical License
    PA State Medical License 2014 - 2015
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Merit Award Conquer Cancer Foundation of ASCO, 2018
  • Scholarship Recipient Mhari Saito No Stomach for Cancer, 2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Palliative Head and Neck Cancer Treatment for Asymptomatic Disease  
    Yerramilli D, Chan A, Margalit D, Otolaryngology�Head and Neck Surgery, 1/27/2018
  • On cultivating the courage to speak up: The critical role of attendings in the moral development of physicians in training  
    Yerramilli D., Hastings Center Report., 1/1./2014
  • SUPPORT asked the wrong question  
    Merz JF, Yerramilli D., The American Journal of Bioethics., 1/1./2013

Books/Book Chapters

Abstracts/Posters

  • Adjuvant chemotherapy after trimodality therapy in locally advanced esophageal cancer.
    Yerramilli D, Sohal D, Teitelbaum UR, Wissel PS, Damjanov N, Giantonio BJ, O'Dwyer PJ, Plastaras JP, BenJosef E, Metz JM, Kucharczuk J, GI ASCO, San Francisco, CA, 1/1/2014
  • Cancer-Related Morbidity at the End-of-Life in Men with Prostate Cancer
    Yerramilli D. Walsh E, Turner E, Young G, Nipp R, Donovan JL, Hamdy FC, Neal D, Martin R, Temel J, Zietman A, ASCO, Chicago, IL, 1/2./2018
  • Defining Cancer-Related Mortality.
    Yerramilli D, Annual Bioethics Conference: Defining Death, Harvard Medical School, Boston, MA, 1/12/2018

Lectures

  • Cancer-related morbidity at the end of life in men with prostate cancer. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Other

Press Mentions

  • Medicine Is a Team Sport, and We Will Only Beat This Pandemic if We Work Together
    Medicine Is a Team Sport, and We Will Only Beat This Pandemic if We Work TogetherMarch 28th, 2020
  • Ethical Issues in Patients Referred for Palliative Radiation Therapy
    Ethical Issues in Patients Referred for Palliative Radiation TherapyJune 2nd, 2019
  • Improving Prognostic Guidance for Men with Advanced and Progressive Forms of Prostate Cancer
    Improving Prognostic Guidance for Men with Advanced and Progressive Forms of Prostate CancerJune 21st, 2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: